These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 22664371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 4. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, Jensen UJ, Tödt T, Götberg M, James SK.
    J Am Coll Cardiol; 2014 Jul 08; 64(1):16-24. PubMed ID: 24998123
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug 08; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 6. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H, Nammas W, Kervinen K, Mikkelsson J, Pietilä M, Lalmand J, Rivero-Crespo F, Pentikäinen M, Tedjokusumo P, Karjalainen PP.
    Minerva Cardioangiol; 2013 Apr 08; 61(2):201-9. PubMed ID: 23492603
    [Abstract] [Full Text] [Related]

  • 7. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 08; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.
    Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134
    [Abstract] [Full Text] [Related]

  • 9. Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.
    Kübler P, Jankowska EA, Ferenc M, Ponikowski P, Banasiak W, Reczuch K.
    Kardiol Pol; 2013 Apr 15; 71(1):25-31. PubMed ID: 23348530
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE, Kuijt WJ, Damman P, Beijk MA, Grundeken MJ, Woudstra P, Tijssen JG, de Winter RJ.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(2):203-9. PubMed ID: 22508617
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P, Motovska Z, Belardi J, Serruys P, Silber S, Windecker S, Neumann FJ.
    Int J Cardiol; 2013 Oct 09; 168(4):3522-6. PubMed ID: 23706326
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.
    Circ Cardiovasc Interv; 2008 Dec 09; 1(3):176-84. PubMed ID: 20031676
    [Abstract] [Full Text] [Related]

  • 13. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
    Siudak Z, Dziewierz A, Rakowski T, Żmudka K, Legutko J, Bartuś S, Dragan J, Zasada W, Tokarek T, Kułaga T, Partyka Ł, Dudek D.
    Catheter Cardiovasc Interv; 2014 Feb 15; 83(3):436-42. PubMed ID: 24038740
    [Abstract] [Full Text] [Related]

  • 14. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
    Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.
    J Invasive Cardiol; 2010 Jun 15; 22(6):266-70. PubMed ID: 20516505
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.
    Crit Pathw Cardiol; 2008 Dec 15; 7(4):232-8. PubMed ID: 19050419
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW.
    J Am Coll Cardiol; 2013 Aug 06; 62(6):496-504. PubMed ID: 23747778
    [Abstract] [Full Text] [Related]

  • 17. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK.
    Int J Cardiol; 2013 Jul 01; 166(3):596-600. PubMed ID: 22192297
    [Abstract] [Full Text] [Related]

  • 18. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
    Assali A, Vaduganathan M, Vaknin-Assa H, Lev EI, Brosh D, Teplitsky I, Bental T, Battler A, Kornowski R.
    Am J Cardiol; 2012 Jun 01; 109(11):1563-8. PubMed ID: 22440117
    [Abstract] [Full Text] [Related]

  • 19. Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial.
    Liu HL, Jin ZG, Yang SL, Han W, Jing QM, Zhang L, Luo JP, Ma DX, Liu Y, Yang LX, Jiang TM, Qu P, Li WM, Li SM, Xu B, Gao RL, Han YL.
    J Cardiol; 2017 Jan 01; 69(1):149-155. PubMed ID: 26972344
    [Abstract] [Full Text] [Related]

  • 20. Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial.
    Pedersen SH, Pfisterer M, Kaiser C, Jensen JS, Alber H, Rickenbacher P, Sørensen R, Iversen A, Jensen MT, Wadt K, Galatius S, BASKET-PROVE Investigators.
    EuroIntervention; 2014 May 01; 10(1):58-64. PubMed ID: 24694667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.